{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T20:36:17Z","timestamp":1780432577333,"version":"3.54.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T00:00:00Z","timestamp":1618272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T00:00:00Z","timestamp":1618272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Anaesthesist"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s00101-021-00946-3","type":"journal-article","created":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T19:08:51Z","timestamp":1618340931000},"page":"717-730","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Spezielle intensivmedizinische Krankheitsbilder der schwangeren Patientin","Special pathologies of pregnant patients in intensive care medicine"],"prefix":"10.1007","volume":"70","author":[{"given":"Sophie","family":"Neuhaus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Neuhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus A.","family":"Weigand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothee","family":"Bremerich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,13]]},"reference":[{"issue":"1","key":"946_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejogrb.2013.05.005","volume":"170","author":"E Abalos","year":"2013","unstructured":"Abalos\u00a0E et\u00a0al (2013) Global and regional estimates of preeclampsia and eclampsia: a\u00a0systematic review. Eur J Obstet Gynecol Reprod Biol 170(1):1\u20137","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"946_CR2","doi-asserted-by":"publisher","first-page":"f6564","DOI":"10.1136\/bmj.f6564","volume":"347","author":"CV Ananth","year":"2013","unstructured":"Ananth\u00a0CV, Keyes\u00a0KM, Wapner\u00a0RJ (2013) Pre-eclampsia rates in the United States, 1980\u20132010: age-period-cohort analysis. BMJ 347:f6564","journal-title":"BMJ"},{"issue":"1","key":"946_CR3","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.preghy.2014.10.075","volume":"5","author":"D Woelkers","year":"2015","unstructured":"Woelkers\u00a0D et al (2015) [71-OR]: The revised 2013 ACOG definitions of hypertensive disorders of pregnancy significantly increase the diagnostic prevalence of preeclampsia. Pregnancy Hypertens 5(1):38","journal-title":"Pregnancy Hypertens"},{"issue":"5","key":"946_CR4","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1097\/01.AOG.0000437382.03963.88","volume":"122","author":"ACOG","year":"2013","unstructured":"ACOG (2013) Hypertension in pregnancy. Report of the American College of Obstetricians and gynecologists\u2019 task force on hypertension in pregnancy. Obstet Gynecol 122(5):1122\u20131131","journal-title":"Obstet Gynecol"},{"key":"946_CR5","volume-title":"NICE Guideline CG107, hypertension in pregnancy: the management of hypertensive disorders during pregnancy","author":"National Institute for Health and Clinical Excellence","year":"2010","unstructured":"National Institute for Health and Clinical Excellence (2010) NICE Guideline CG107, hypertension in pregnancy: the management of hypertensive disorders during pregnancy"},{"key":"946_CR6","volume-title":"S2k-Leitlinie 015\/018: Diagnostik und Therapie hypertensiver Schwangerschaftserkrankungen","author":"Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF)","year":"2019","unstructured":"Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF) (2019) S2k-Leitlinie 015\/018: Diagnostik und Therapie hypertensiver Schwangerschaftserkrankungen"},{"key":"946_CR7","volume-title":"Saving Lives, Improving Mothers\u2019 Care-Lessons learned to inform future maternity care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2009\u201312","author":"M Knight","year":"2014","unstructured":"MBRRACE-UK, Knight\u00a0M et al (2014) Saving Lives, Improving Mothers\u2019 Care-Lessons learned to inform future maternity care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2009\u201312. National Perinatal Epidemiology Unit, University of Oxford, Oxford"},{"key":"946_CR8","unstructured":"National Health Service and National Institute for Health and Care Excellence. (2019) Guideline \u201eHypertension in pregnancy: diagnosis and management\u201c (NG133). https:\/\/www.nice.org.uk\/guidance\/ng133\/resources\/visual-summaries-8720711389. Zugegriffen: 16. Aug. 2020"},{"issue":"11","key":"946_CR9","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1080\/14767058.2017.1416604","volume":"32","author":"M Cavaignac-Vitalis","year":"2019","unstructured":"Cavaignac-Vitalis\u00a0M et al (2019) Conservative versus active management in HELLP syndrome: results from a\u00a0cohort study. J\u00a0Matern Fetal Neonatal Med 32(11):1769\u20131775","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"3","key":"946_CR10","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1097\/AOG.0000000000000140","volume":"123","author":"KE Fitzpatrick","year":"2014","unstructured":"Fitzpatrick\u00a0KE et\u00a0al (2014) Risk factors, management, and outcomes of hemolysis, elevated liver enzymes, and low platelets syndrome and elevated liver enzymes, low platelets syndrome. Obstet Gynecol 123(3):618\u2013627","journal-title":"Obstet Gynecol"},{"key":"946_CR11","unstructured":"Deutsche Gesellschaft f\u00fcr Anaesthesiologie und Intensivmedizin and Deutsche Gesellschaft f\u00fcr Gyn\u00e4kologie und Geburtshilfe. (2020) S1-Leitlinie \u201eDie geburtshilfliche Analgesie und An\u00e4sthesie\u201c (Registernummer 001-038). https:\/\/www.awmf.org\/uploads\/tx_szleitlinien\/001-038l_S1_Die-geburtshilfliche-Analgesie-und-Anaesthesie_2020-03.pdf. Zugegriffen: 16. Aug. 2020"},{"key":"946_CR12","unstructured":"Deutsche Gesellschaft f\u00fcr Gyn\u00e4kologie und Geburtshilfe, \u00d6sterreichische Gesellschaft f\u00fcr Gyn\u00e4kologie und Geburtshilfe, Schweizerische Gesellschaft f\u00fcr Gyn\u00e4kologie und Geburtshilfe (2019) S2k-Leitlinie \u201eHypertensive Schwangerschaftserkrankungen: Diagnostik und Therapie\u201c (Registernummer 015-018). https:\/\/www.awmf.org\/uploads\/tx_szleitlinien\/015-018l_S2k_Diagnostik_Therapie_hypertensiver_Schwangerschaftserkrankungen_2019-07.pdf. Zugegriffen: 16. Aug. 2020"},{"issue":"9761","key":"946_CR13","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S0140-6736(10)61351-7","volume":"377","author":"P von Dadelszen","year":"2011","unstructured":"von Dadelszen\u00a0P et al (2011) Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model. Lancet 377(9761):219\u2013227","journal-title":"Lancet"},{"issue":"20","key":"946_CR14","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1056\/NEJM199611143352002","volume":"335","author":"HP Schobel","year":"1996","unstructured":"Schobel\u00a0HP et\u00a0al (1996) Preeclampsia\u2014a\u00a0state of sympathetic overactivity. N\u00a0Engl J Med 335(20):1480\u20131485","journal-title":"N Engl J Med"},{"issue":"6","key":"946_CR15","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1213\/ANE.0000000000000424","volume":"119","author":"M Pant","year":"2014","unstructured":"Pant\u00a0M, Fong\u00a0R, Scavone\u00a0B (2014) Prevention of peri-induction hypertension in preeclamptic patients: a\u00a0focused review. Anesth Analg 119(6):1350\u20131356","journal-title":"Anesth Analg"},{"issue":"1","key":"946_CR16","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.bpa.2016.12.002","volume":"31","author":"R Hofmeyr","year":"2017","unstructured":"Hofmeyr\u00a0R, Matjila\u00a0M, Dyer\u00a0R (2017) Preeclampsia in 2017: obstetric and anaesthesia management. Best Pract Res Clin Anaesthesiol 31(1):125\u2013138","journal-title":"Best Pract Res Clin Anaesthesiol"},{"issue":"1","key":"946_CR17","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1093\/bja\/79.1.122","volume":"79","author":"B Kussman","year":"1997","unstructured":"Kussman\u00a0B et\u00a0al (1997) Administration of magnesium sulphate before rocuronium: effects on speed of onset and duration of neuromuscular block. Br J Anaesth 79(1):122\u2013124","journal-title":"Br J Anaesth"},{"issue":"1","key":"946_CR18","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/ALN.0000000000000204","volume":"121","author":"C Czarnetzki","year":"2014","unstructured":"Czarnetzki\u00a0C et al (2014) Efficacy of sugammadex for the reversal of moderate and deep rocuronium-induced neuromuscular block in patients pretreated with intravenous magnesium: a\u00a0randomized controlled trial. Anesthesiology 121(1):59\u201367","journal-title":"Anesthesiology"},{"key":"946_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001805","author":"L Duley","year":"2000","unstructured":"Duley\u00a0L, Williams\u00a0J, Henderson-Smart\u00a0DJ (2000) Plasma volume expansion for treatment of women with pre-eclampsia. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD001805","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"946_CR20","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1093\/bja\/aev221","volume":"115","author":"CM Ortner","year":"2015","unstructured":"Ortner\u00a0CM et\u00a0al (2015) Strong ion and weak acid analysis in severe preeclampsia: potential clinical significance. Br J Anaesth 115(2):275\u2013284","journal-title":"Br J Anaesth"},{"issue":"2","key":"946_CR21","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.ijoa.2010.11.007","volume":"20","author":"AT Dennis","year":"2011","unstructured":"Dennis\u00a0AT (2011) Transthoracic echocardiography in obstetric anaesthesia and obstetric critical illness. Int J Obstet Anesth 20(2):160\u2013168","journal-title":"Int J Obstet Anesth"},{"issue":"Suppl 1","key":"946_CR22","doi-asserted-by":"publisher","first-page":"S51","DOI":"10.1016\/j.accpm.2016.06.005","volume":"35","author":"L Zieleskiewicz","year":"2016","unstructured":"Zieleskiewicz\u00a0L et\u00a0al (2016) Intensive care and pregnancy: epidemiology and general principles of management of obstetrics ICU patients during pregnancy. Anaesth Crit Care Pain Med 35(Suppl 1):S51\u2013S57","journal-title":"Anaesth Crit Care Pain Med"},{"issue":"3","key":"946_CR23","doi-asserted-by":"publisher","first-page":"302","DOI":"10.4103\/aca.ACA_88_18","volume":"22","author":"AS Nagre","year":"2019","unstructured":"Nagre\u00a0AS (2019) Focus-assessed transthoracic echocardiography: Implications in perioperative and intensive care. Ann Card Anaesth 22(3):302\u2013308","journal-title":"Ann Card Anaesth"},{"issue":"7","key":"946_CR24","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.echo.2014.05.001","volume":"27","author":"G Via","year":"2014","unstructured":"Via\u00a0G et al (2014) International evidence-based recommendations for focused cardiac ultrasound. J\u00a0Am Soc Echocardiogr 27(7):e1\u2013683.e3","journal-title":"J Am Soc Echocardiogr"},{"issue":"2","key":"946_CR25","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ijoa.2012.11.001","volume":"22","author":"N Afshani","year":"2013","unstructured":"Afshani\u00a0N et al (2013) Utility of B\u2011type natriuretic peptides in preeclampsia: a\u00a0systematic review. Int J Obstet Anesth 22(2):96\u2013103","journal-title":"Int J Obstet Anesth"},{"issue":"2","key":"946_CR26","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1515\/cclm-2013-0307","volume":"52","author":"G Szab\u00f3","year":"2014","unstructured":"Szab\u00f3\u00a0G et al (2014) Increased B\u2011type natriuretic peptide levels in early-onset versus late-onset preeclampsia. Clin Chem Lab Med 52(2):281\u2013288","journal-title":"Clin Chem Lab Med"},{"key":"946_CR27","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ijoa.2018.06.005","volume":"36","author":"G Brzan Simenc","year":"2018","unstructured":"Brzan Simenc\u00a0G et\u00a0al (2018) Ocular ultrasonography for diagnosing increased intracranial pressure in patients with severe preeclampsia. Int J Obstet Anesth 36:49\u201355","journal-title":"Int J Obstet Anesth"},{"issue":"4","key":"946_CR28","doi-asserted-by":"publisher","first-page":"377","DOI":"10.2478\/raon-2018-0047","volume":"52","author":"GB Simenc","year":"2018","unstructured":"Simenc\u00a0GB et\u00a0al (2018) Optic nerve ultrasound for fluid status assessment in patients with severe preeclampsia. Radiol Oncol 52(4):377\u2013382","journal-title":"Radiol Oncol"},{"key":"946_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijoa.2019.09.002","volume":"41","author":"CM Ortner","year":"2020","unstructured":"Ortner\u00a0CM et al (2020) Ocular sonography in pre-eclampsia: a\u00a0simple technique to detect raised intracranial pressure? Int J Obstet Anesth 41:1\u20136","journal-title":"Int J Obstet Anesth"},{"issue":"11","key":"946_CR30","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1097\/CCM.0000000000000519","volume":"42","author":"P Guerci","year":"2014","unstructured":"Guerci\u00a0P et al (2014) Cerebral oximetry assessed by near-infrared spectrometry during preeclampsia: an observational study: impact of magnesium sulfate administration. Crit Care Med 42(11):2379\u20132386","journal-title":"Crit Care Med"},{"key":"946_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008363.pub2","author":"T Stampalija","year":"2010","unstructured":"Stampalija\u00a0T, Gyte\u00a0GM, Alfirevic\u00a0Z (2010) Utero-placental Doppler ultrasound for improving pregnancy outcome. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD008363.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"946_CR32","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer\u00a0M et al (2016) The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA 315(8):801\u2013810","journal-title":"JAMA"},{"issue":"6","key":"946_CR33","doi-asserted-by":"publisher","first-page":"400","DOI":"10.14740\/jocmr2118w","volume":"7","author":"L Oud","year":"2015","unstructured":"Oud\u00a0L, Watkins\u00a0P (2015) Evolving trends in the epidemiology, resource utilization, and outcomes of pregnancy-associated severe sepsis: a\u00a0population-based cohort study. J\u00a0Clin Med Res 7(6):400\u2013416","journal-title":"J Clin Med Res"},{"issue":"7","key":"946_CR34","doi-asserted-by":"publisher","first-page":"e1001672","DOI":"10.1371\/journal.pmed.1001672","volume":"11","author":"CD Acosta","year":"2014","unstructured":"Acosta\u00a0CD et al (2014) Severe maternal sepsis in the UK, 2011\u20132012: a\u00a0national case-control study. PLoS Med 11(7):e1001672","journal-title":"PLoS Med"},{"issue":"5","key":"946_CR35","doi-asserted-by":"publisher","first-page":"e661","DOI":"10.1016\/S2214-109X(20)30109-1","volume":"8","author":"The WHO Global Maternal Sepsis Study (GLOSS) Research Group","year":"2020","unstructured":"The WHO Global Maternal Sepsis Study (GLOSS) Research Group (2020) Frequency and management of maternal infection in health facilities in 52\u00a0countries (GLOSS): a\u00a01-week inception cohort study. Lancet Glob Health 8(5):e661\u2013e671","journal-title":"Lancet Glob Health"},{"key":"946_CR36","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ijoa.2018.04.010","volume":"36","author":"CEG Burlinson","year":"2018","unstructured":"Burlinson\u00a0CEG et\u00a0al (2018) Sepsis in pregnancy and the puerperium. Int J Obstet Anesth 36:96\u2013107","journal-title":"Int J Obstet Anesth"},{"key":"946_CR37","volume-title":"Saving Lives, Improving Mothers\u2019 Care\u2014Lessons learned to inform maternity care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2015\u201317","author":"M Knight","year":"2019","unstructured":"MBRRACE-UK, Knight\u00a0M et al (2019) Saving Lives, Improving Mothers\u2019 Care\u2014Lessons learned to inform maternity care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2015\u201317. National Perinatal Epidemiology Unit, Oxford"},{"issue":"4","key":"946_CR38","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1056\/NEJMoa1207210","volume":"368","author":"SE H\u00e5berg","year":"2013","unstructured":"H\u00e5berg\u00a0SE et\u00a0al (2013) Risk of fetal death after pandemic influenza virus infection or vaccination. N\u00a0Engl J Med 368(4):333\u2013340","journal-title":"N Engl J Med"},{"issue":"3","key":"946_CR39","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.chest.2017.12.015","volume":"153","author":"R Serafim","year":"2018","unstructured":"Serafim\u00a0R et al (2018) A comparison of the quick-SOFA and systemic inflammatory response syndrome criteria for the diagnosis of sepsis and prediction of mortality: a\u00a0systematic review and meta-analysis. Chest 153(3):646\u2013655","journal-title":"Chest"},{"issue":"7","key":"946_CR40","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1111\/anae.12708","volume":"69","author":"RA Isaacs","year":"2014","unstructured":"Isaacs\u00a0RA et\u00a0al (2014) A national survey of obstetric early warning systems in the United Kingdom: five\u00a0years on. Anaesthesia 69(7):687\u2013692","journal-title":"Anaesthesia"},{"issue":"Suppl 1","key":"946_CR41","first-page":"1","volume":"118","author":"R Cantwell","year":"2011","unstructured":"Cantwell\u00a0R et\u00a0al (2011) Saving mothers\u2019 lives: reviewing maternal deaths to make motherhood safer: 2006\u20132008. The eighth report of the confidential enquiries into maternal deaths in the united kingdom. BJOG 118(Suppl 1):1\u2013203","journal-title":"BJOG"},{"issue":"3","key":"946_CR42","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1097\/CCM.0000000000002255","volume":"45","author":"A Rhodes","year":"2017","unstructured":"Rhodes\u00a0A et\u00a0al (2017) Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Crit Care Med 45(3):486\u2013552","journal-title":"Crit Care Med"},{"issue":"6","key":"946_CR43","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s00134-018-5085-0","volume":"44","author":"MM Levy","year":"2018","unstructured":"Levy\u00a0MM, Evans\u00a0LE, Rhodes\u00a0A (2018) The surviving sepsis campaign bundle: 2018 update. Intensive Care Med 44(6):925\u2013928","journal-title":"Intensive Care Med"},{"key":"946_CR44","unstructured":"The Sepsis Trust (2017) Inpatient maternal sepsis tool. https:\/\/sepsistrust.org\/wp-content\/uploads\/2018\/06\/Inpatient-maternal-NICE-Final-1107-2.pdf. Zugegriffen: 16. Aug. 2020"},{"issue":"3","key":"946_CR45","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1097\/ACO.0000000000000339","volume":"29","author":"V Patil","year":"2016","unstructured":"Patil\u00a0V, Wong\u00a0M, Wijayatilake\u00a0DS (2016) Clinical \u2018Pearls\u2019 of maternal critical care: part I. Curr Opin Anaesthesiol 29(3):304\u2013316","journal-title":"Curr Opin Anaesthesiol"},{"key":"946_CR46","volume-title":"S2k-Leitlinie 015\/063: Peripartale Blutungen, Diagnostik und Therapie","author":"Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF)","year":"2016","unstructured":"Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF) (2016) S2k-Leitlinie 015\/063: Peripartale Blutungen, Diagnostik und Therapie"},{"issue":"5","key":"946_CR47","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1097\/AOG.0000000000003513","volume":"134","author":"J Viau-Lapointe","year":"2019","unstructured":"Viau-Lapointe\u00a0J, Filewod\u00a0N (2019) Extracorporeal therapies for amniotic fluid embolism. Obstet Gynecol 134(5):989\u2013994","journal-title":"Obstet Gynecol"},{"issue":"3","key":"946_CR48","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1097\/ACO.0000000000000328","volume":"29","author":"P Sultan","year":"2016","unstructured":"Sultan\u00a0P, Seligman\u00a0K, Carvalho\u00a0B (2016) Amniotic fluid embolism: update and review. Curr Opin Anaesthesiol 29(3):288\u2013296","journal-title":"Curr Opin Anaesthesiol"},{"issue":"7","key":"946_CR49","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1002\/ccr3.316","volume":"3","author":"Y Todo","year":"2015","unstructured":"Todo\u00a0Y et\u00a0al (2015) Therapeutic application of C1 esterase inhibitor concentrate for clinical amniotic fluid embolism: a\u00a0case report. Clin Case Rep 3(7):673","journal-title":"Clin Case Rep"},{"issue":"6","key":"946_CR50","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1111\/jog.12428","volume":"40","author":"N Kanayama","year":"2014","unstructured":"Kanayama\u00a0N, Tamura\u00a0N (2014) Amniotic fluid embolism: pathophysiology and new strategies for management. J\u00a0Obstet Gynaecol Res 40(6):1507\u20131517","journal-title":"J Obstet Gynaecol Res"},{"issue":"24","key":"946_CR51","doi-asserted-by":"publisher","first-page":"3147","DOI":"10.1093\/eurheartj\/ehr218","volume":"32","author":"V Regitz-Zagrosek","year":"2011","unstructured":"European Society of Gynecology (ESG), Association for European Paediatric Cardiology (AEPC), German Society for Gender Medicine (DGesGM), Regitz-Zagrosek\u00a0V et al (2011) ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart\u00a0J 32(24):3147\u20133197","journal-title":"Eur Heart J"},{"issue":"4","key":"946_CR52","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1097\/AOG.0000000000000746","volume":"125","author":"EK Main","year":"2015","unstructured":"Main\u00a0EK et al (2015) Pregnancy-related mortality in California: causes, characteristics, and improvement opportunities. Obstet Gynecol 125(4):938\u2013947","journal-title":"Obstet Gynecol"},{"issue":"8","key":"946_CR53","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1093\/eurjhf\/hfq120","volume":"12","author":"K Sliwa","year":"2010","unstructured":"Sliwa\u00a0K et\u00a0al (2010) Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a\u00a0position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail 12(8):767\u2013778","journal-title":"Eur J Heart Fail"},{"issue":"14","key":"946_CR54","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1161\/CIRCULATIONAHA.115.020491","volume":"133","author":"Z Arany","year":"2016","unstructured":"Arany\u00a0Z, Elkayam\u00a0U (2016) Peripartum cardiomyopathy. Circulation 133(14):1397\u20131409","journal-title":"Circulation"}],"container-title":["Der Anaesthesist"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00101-021-00946-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00101-021-00946-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00101-021-00946-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T11:19:02Z","timestamp":1675163942000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00101-021-00946-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,13]]},"references-count":54,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["946"],"URL":"https:\/\/doi.org\/10.1007\/s00101-021-00946-3","relation":{},"ISSN":["0003-2417","1432-055X"],"issn-type":[{"value":"0003-2417","type":"print"},{"value":"1432-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,13]]},"assertion":[{"value":"1 March 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"<b>S.\u00a0Neuhaus:<\/b>\u00a0A.\u00a0Finanzielle Interessen: S.\u00a0Neuhaus gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Wiss. Mitarbeiterin, Klinik f\u00fcr An\u00e4sthesiologie, Universit\u00e4tsklinikum Heidelberg.<b>C.\u00a0Neuhaus:<\/b> A.\u00a0Finanzielle Interessen: C.\u00a0Neuhaus gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Oberarzt, Klinik f\u00fcr An\u00e4sthesiologie, Universit\u00e4tsklinikum Heidelberg.<b>D.\u00a0Bremerich:<\/b> A.\u00a0Finanzielle Interessen: Erstattung der Teilnehmergeb\u00fchren, Reise- und \u00dcbernachtungskosten: Sintetica, TEVA ratiopharm, CSL Behring.\u00a0\u2013 Bezahlter Berater\/interner Schulungsreferent\/Gehaltsempf\u00e4nger o.\u202f\u00e4.: Sintetica, TEVA ratiopharm.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Ober\u00e4rztin, Klinik f\u00fcr An\u00e4sthesiologie, Universit\u00e4tsmedizin Mainz\u00a0| Mitgliedschaften: DGAI, BDA.<b>M.\u00a0Weigand:<\/b> A.\u00a0Finanzielle Interessen: Forschungsf\u00f6rderung zur pers\u00f6nlichen Verf\u00fcgung: K\u00f6hler Chemie.\u00a0\u2013 Referentenhonorar oder Kostenerstattung als passiver Teilnehmer: MSD, Pfizer, Astellas, Cytosorb, K\u00f6hler Chemie, Shionogi, Eumedica, Gilead.\u00a0\u2013 Advisory Board: MSD, Shionogi, Gilead, Eumedica.\u00a0\u2013 Patente, Gesch\u00e4ftsanteile, Aktien o.\u202f\u00e4. an einer im Medizinbereich aktiven Firma: Delta Theragnostics (Start up zur Translation des Biomarkers DLL).\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: \u00c4rztlicher Direktor, Klinik f\u00fcr An\u00e4sthesiologie, Universit\u00e4tsklinikum Heidelberg\u00a0| Mitgliedschaften: DSG (Vorsitzender), DGAI, BDA, DIVI, PEG (wissenschaftlicher Beirat).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}